Health & Safety

August 10, 2012

Laboratory developed tests covered under TRICARE demonstration may help guide cancer treatment decisions

by TRICARE Public Affairs

Some TRICARE beneficiaries will soon be able to take advantage of new technologies aimed at helping patients and healthcare providers make more informed decisions regarding treatment options for surgery, chemotherapy or radiation therapy for some types of cancer.

On May 22, 2012, two laboratory developed tests were approved for coverage by TRICARE under a demonstration project: the BRACAnalysis BRCA1 and BRCA2 tests (Myriad Genetic Laboratories, Inc.), and also, the Oncotype DX Breast Cancer Assay (Genomic Health, Inc.).

BRACAnalysis testing assesses a woman’s risk of developing hereditary breast or ovarian cancers based on detection of mutations in their BRCA1 and BRCA2 genes. The Oncotype DX breast cancer assay is a test that examines a breast cancer patient’s tumor tissue at the molecular level; specifically, it is hoped that this information can help individualize the planning of the patient’s breast cancer treatment. The complete description of this demonstration project is available at www.gpo.gov/fdsys/pkg/FR-2011-12-27/html/2011-33066.htm.

The criteria for which of these tests will be covered by TRICARE are scheduled to be published in the TRICARE Operations Manual in August 2012. TRICARE providers will be prepared to accept patients under the demonstration project by September 30, 2012; however, coverage for the approved use of these tests is retroactive to May 22, 2012. Beneficiaries should speak with their primary health care professional or their regional contractor to determine their eligibility for having these tests performed as a TRICARE benefit. Find regional contractor contact information at www.tricare.mil/contactus.




All of this week's top headlines to your email every Friday.


 
 

 
MDG-no-show

Don’t be a ‘no show’

The 412th Medical Group is dedicated to meeting the health care needs of you and your family by providing access to its services and the best possible medical care. No shows are a costly problem for the 412th MDG and the patien...
 
 

TRICARE and the Affordable Care Act

With the implementation of the Patient Protection and Affordable Care Act in 2010, TRICARE beneficiaries may have questions about how it would affect them. The ACA and TRICARE are very different, governed by two different pieces of legislation so changes in one have no effect on the other. The intent of the Affordable Care Act,...
 
 
heart-month

AFMC promotes awareness of heart attack warning signs

February is American Heart Month. The National Institutes of Health reports that more than one million people in the United States have a heart attack each year. Of the people who die from heart attacks, about half die within a...
 

 

Air Force Fitness Management System II up, accessible

The new Air Force Fitness Management System ñ AFFMS II ñ is now up and accessible via the Air Force Personnel Center Secure Application, Air Force Personnel Center officials said. AFFMS II enables Airmen to review their fitness history and records through July 2010. The previous system was taken off line Dec. 31 to enable...
 
 
Air Force photograph by Ethan Wagner

Edwards AFB’s Biomedical Sciences Corps team celebrates 50 years

Air Force photograph by Ethan Wagner The Biomedical Sciences Corps is made up of 2,400 professionals in a range of fields including optometry. Maj. Jade Texcell provides an optometry exam to an Airman.   Do you enjoy havin...
 
 
sharps

Safe personal disposal of sharps

At the 412th Medical Group, we recognize proper management and disposal of sharps safely reduces pollution, prevents injury, and averts disease transmission. A sharp is generally any hypodermic needle, pen needle, intravenous n...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>